| Literature DB >> 34408775 |
Chi Tim Leung1,2, Yi Yang1,3, Kwan Ngok Yu4,5, Nathan Tam2, Ting Fung Chan6, Xiao Lin6, Richard Yuen Chong Kong1,2,4, Jill Man Ying Chiu1,7, Alice Sze Tsai Wong1,3, Wing Yee Lui3, Karen Wing Yee Yuen3, Keng Po Lai1,2,4,8, Rudolf Shiu Sun Wu1,4,9.
Abstract
Humans are regularly and continuously exposed to ionizing radiation from both natural and artificial sources. Cumulating evidence shows adverse effects of ionizing radiation on both male and female reproductive systems, including reduction of testis weight and sperm count and reduction of female germ cells and premature ovarian failure. While most of the observed effects were caused by DNA damage and disturbance of DNA repairment, ionizing radiation may also alter DNA methylation, histone, and chromatin modification, leading to epigenetic changes and transgenerational effects. However, the molecular mechanisms underlying the epigenetic changes and transgenerational reproductive impairment induced by low-dose radiation remain largely unknown. In this study, two different types of human ovarian cells and two different types of testicular cells were exposed to low dose of ionizing radiation, followed by bioinformatics analysis (including gene ontology functional analysis and Ingenuity Pathway Analysis), to unravel and compare epigenetic effects and pathway changes in male and female reproductive cells induced by ionizing radiation. Our findings showed that the radiation could alter the expression of gene cluster related to DNA damage responses through the control of MYC. Furthermore, ionizing radiation could lead to gender-specific reproductive impairment through deregulation of different gene networks. More importantly, the observed epigenetic modifications induced by ionizing radiation are mediated through the alteration of chromatin remodeling and telomere function. This study, for the first time, demonstrated that ionizing radiation may alter the epigenome of germ cells, leading to transgenerational reproductive impairments, and correspondingly call for research in this new emerging area which remains almost unknown.Entities:
Keywords: environmental radiation; epigenetic; ovarian; reproductive impairments; testicular
Year: 2021 PMID: 34408775 PMCID: PMC8365519 DOI: 10.3389/fgene.2021.710143
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1The ionizing radiation exposure (10 cGy) has no effect on the cell viability of SKOV3, COV434, GC-1, and TM4 cells. The white bar represented the control group; the black bar represented the ionizing radiation group. N.s., not statistically significant.
FIGURE 2The ionizing radiation exposure caused the differential gene expression in male reproductive cells. (A) Volcano plot showed the differentially expressed genes in the TM4 cells. Green dots represented downregulated genes. Red dots represented upregulated genes. (B) Volcano plot showed the differentially expressed genes in the GC-1 cells. Green dots represented downregulated genes. Red dots represented upregulated genes. (C) Common deregulated genes in TM4 and GC-1 cells under the ionizing radiation exposure.
Common deregulated genes in SKOV3 and COV434 after radiation exposure.
| Common | |
| ABHD14A-ACY1 | 6.321928095 |
| AGAP6 | −0.26995382 |
| AHNAK | −0.036692267 |
| ANKRD52 | −0.125579585 |
| BHLHE40 | 0.159297821 |
| CCNB1 | 0.118534794 |
| CCT8 | 0.112181258 |
| CELSR1 | −0.169768603 |
| CEP170B | −0.203081668 |
| CLK1 | −0.581517732 |
| CYR61 | 0.50372215 |
| DAG1 | −0.137058218 |
| DNAJB1 | 0.421062267 |
| FLNA | −0.137776264 |
| FLNB | −0.101035897 |
| HCFC1 | −0.256265359 |
| HMGA2 | −0.279167524 |
| HSPA1A | 0.674635288 |
| HSPA1B | 0.802124194 |
| HSPA8 | 0.522838677 |
| HSPE1-MOB4 | 1.696165063 |
| HSPG2 | −0.131589484 |
| ILF3 | −0.117865207 |
| KMT2D | −0.128633535 |
| LARP1 | −0.130260559 |
| LDHA | 0.070238521 |
| LENG8 | −0.167621054 |
| MAP3K14 | −0.246671519 |
| MSH5 | −1.036220188 |
| MTRNR2L1 | 0.086443006 |
| MTRNR2L2 | 0.055259141 |
| MTRNR2L6 | 0.366614351 |
| MTRNR2L8 | 0.07506049 |
| MYC | 0.465690304 |
| NACA | 0.066625449 |
| NBPF11 | −2.273922722 |
| NDST1 | −0.324568416 |
| NOL9 | −0.227755207 |
| NOMO3 | 0.261103909 |
| PKD1 | −0.212287115 |
| PLEC | −0.211283151 |
| POLE | −0.149276115 |
| PPP1R15A | 0.341577734 |
| PRRC2B | −0.102852978 |
| RHOB | 0.332811579 |
| RPS17 | 8.515699838 |
| SH3BP4 | −0.306432533 |
| SMAD3 | −0.169052451 |
| SNRNP200 | −0.082025905 |
| SRCAP | −0.18936661 |
| SRRM2 | −0.08339425 |
| TCP1 | 0.131439798 |
| TJP1 | −0.138449491 |
| TMEM189-UBE2V1 | −4.906890596 |
| TNRC18 | −0.247618398 |
| TPT1 | 0.082415032 |
| TPX2 | 0.109746859 |
| TRIO | −0.102527386 |
| UBR4 | −0.100565996 |
FIGURE 3The ionizing radiation exposure caused the differential gene expression in female reproductive cells. (A) Volcano plot showed the differentially expressed genes in the SKOV3 cells. Green dots represented downregulated genes. Red dots represented upregulated genes. (B) Volcano plot showed the differential expressed genes in the COV434 cells. Green dots represented downregulated genes. Red dots represented upregulated genes. (C) Common deregulated genes in SKOV3 and COV434 cells under the ionizing radiation exposure.
Common deregulated genes in TM4 and GC-1 after radiation exposure.
| Common | Genes |
| 6820431F20Rik | −0.148053365 |
| Actb | 0.015429673 |
| Actg1 | 0.035451843 |
| Amotl2 | 0.117501459 |
| Atad5 | −0.144339873 |
| Atrx | −0.155713413 |
| Bclaf1 | −0.091555479 |
| Cd209c | −0.538806202 |
| Cd2ap | −0.108090558 |
| Cited2 | 0.074274825 |
| Cmah | −0.055197597 |
| Col1a1 | 0.115874807 |
| Ctgf | 0.213118333 |
| Cxcr2 | 0.239034728 |
| Cyr61 | 0.184896033 |
| Ddx17 | −0.121821168 |
| Dst | −0.118465395 |
| Dusp1 | 0.227403063 |
| Egr1 | 0.294032038 |
| Eif1 | 0.081156225 |
| Eif4a2 | −0.147533967 |
| Flnb | 0.044000894 |
| Fn1 | 0.03142685 |
| Fubp1 | −0.054877449 |
| Hspa8 | 0.027844383 |
| Ier2 | 0.169029369 |
| Ier3 | 0.226920302 |
| Luc7l3 | −0.306875903 |
| Mat2a | −0.098084338 |
| Mki67 | −0.187693922 |
| Myc | 0.09462868 |
| Ncl | −0.055239947 |
| Npm1 | −0.02494927 |
| Pcm1 | −0.107611547 |
| Phlda1 | 0.066301904 |
| Plk2 | 0.129986464 |
| Psip1 | −0.107652929 |
| Ptgs2 | 0.085702 |
| Ranbp2 | −0.106473682 |
| Rhob | 0.100308303 |
| Rplp0 | 0.014678559 |
| Scaf11 | −0.053057537 |
| Serpine1 | 0.060359909 |
| Setd2 | −0.085843794 |
| Smarca5 | −0.063291942 |
| Smc2 | −0.18366615 |
| Smc3 | −0.112639541 |
| Smc4 | −0.145773918 |
| Sparc | 0.081296273 |
| Srsf10 | −0.063547185 |
| Thbs1 | 0.048740214 |
| Tmem254c | −7.996389141 |
| Top2a | −0.085094243 |
| Trpm7 | −0.156997671 |
| Ttc14 | −0.263145409 |
| U2surp | −0.094367453 |
| Ubc | 0.050980317 |
| Zfc3h1 | −0.170572408 |
FIGURE 4Alteration of biological processes and signaling pathways in the reproductive cells caused by the ionizing radiation. (A) Rich factor plot showed the altered biological processes related to DNA damage responses and cell apoptosis and telomere structure in female reproductive cells using Gene Ontology (GO) enrichment analysis. (B) Rich factor plot showed the altered cell signaling pathways in the female reproductive cells after the ionizing radiation exposure using Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. (C) Rich factor plot showed the altered biological processes related to DNA damage and chromosome organization in male reproductive cells using GO enrichment analysis. (D) Rich factor plot showed the altered cell signaling pathways in the male reproductive cells after the ionizing radiation exposure using KEGG analysis. The size of dot represented the number of gene. The color intensity of dot represented the significance of the biological processes and cell signaling pathways.
Gene ontology enrichment analysis on SKOV3 and COV434 common deregulated genes.
| Term | Count | Genes | |
| GO:2001022∼positive regulation of response to DNA damage stimulus | 2 | 0.026451 | MYC, HMGA2 |
| GO:0043066∼negative regulation of apoptotic process | 5 | 0.048141 | SMAD3, FLNA, HMGA2, CYR61, HSPA1B |
| GO:0030308∼negative regulation of cell growth | 3 | 0.037132 | SMAD3, SH3BP4, HSPA1A |
| GO:0007050∼cell cycle arrest | 3 | 0.016601 | SMAD3, MYC, PKD1 |
| GO:0045787∼positive regulation of cell cycle | 2 | 0.092951 | CCNB1, MYC |
| GO:0050821∼protein stabilization | 5 | 2.61E-04 | SMAD3, TCP1, FLNA, CCT8, HCFC1 |
| GO:0006457∼protein folding | 4 | 0.003713 | DNAJB1, HSPA8, TCP1, CCT8 |
| GO:0098609∼cell–cell adhesion | 8 | 3.37E-07 | TJP1, DNAJB1, LDHA, LARP1, FLNB, HCFC1, PLEC, HSPA1A |
| GO:0010628∼positive regulation of gene expression | 5 | 0.015824 | PPP1R15A, HSPA8, SMAD3, HMGA2, HCFC1 |
| GO:0042993∼positive regulation of transcription factor import into nucleus | 2 | 0.038247 | SMAD3, FLNA |
| GO:0001701∼ | 5 | 0.005915 | KMT2D, CCNB1, SMAD3, MYC, PKD1 |
| GO:1904851∼positive regulation of establishment of protein localization to telomere | 2 | 0.021693 | TCP1, CCT8 |
| GO:1904874∼positive regulation of telomerase RNA localization to Cajal body | 2 | 0.035899 | TCP1, CCT8 |
| GO:0032212∼positive regulation of telomere maintenance via telomerase | 2 | 0.075063 | TCP1, CCT8 |
| GO:0031507∼heterochromatin assembly | 2 | 0.009699 | HMGA2, TNRC18 |
| GO:0007339∼binding of sperm to zona pellucida | 3 | 0.003459 | TCP1, CCT8, HSPA1B |
| GO:0060428∼lung epithelium development | 2 | 0.019306 | HMGA2, PKD1 |
| GO:1904871(positive regulation of protein localization to Cajal body | 2 | 0.019306 | TCP1, CCT8 |
| GO:0060236(regulation of mitotic spindle organization | 2 | 0.019306 | TPX2, PKD1 |
| GO:0001649(osteoblast differentiation | 3 | 0.030878 | SMAD3, SNRNP200, CYR61 |
| GO:0051085(chaperone mediated protein folding requiring cofactor | 2 | 0.031186 | DNAJB1, HSPA8 |
| GO:0044319(wound healing, spreading of cells | 2 | 0.031186 | FLNA, CYR61 |
| GO:0006468(protein phosphorylation | 5 | 0.050757 | CLK1, ILF3, CCNB1, TRIO, MAP3K14 |
| GO:0060441(epithelial tube branching involved in lung morphogenesis | 2 | 0.05683 | DAG1, HMGA2 |
| GO:0045216(cell—cell junction organization | 2 | 0.05683 | SMAD3, FLNA |
| GO:0043484∼regulation of RNA splicing | 2 | 0.068266 | CLK1, AHNAK |
| GO:0001837∼epithelial to mesenchymal transition | 2 | 0.072803 | FLNA, HMGA2 |
| GO:0042177∼negative regulation of protein catabolic process | 2 | 0.081811 | SMAD3, FLNA |
| GO:1901998∼toxin transport | 2 | 0.081811 | TCP1, CCT8 |
| GO:0090307∼mitotic spindle assembly | 2 | 0.081811 | TPX2, FLNA |
| GO:0043085∼positive regulation of catalytic activity | 2 | 0.090733 | HSPA8, MYC |
| GO:0045944∼positive regulation of transcription from RNA polymerase II promoter | 6 | 0.092546 | KMT2D, SMAD3, MYC, HMGA2, PKD1, CYR61 |
| GO:0048565∼digestive tract development | 2 | 0.097369 | CCNB1, PKD1 |
KEGG enrichment analysis on SKOV3 and COV434 common deregulated genes.
| Term | Count | Genes | |
| mmu04010:MAPK signaling pathway | 7 | 7.20E-05 | HSPA8, MYC, FLNA, FLNB, MAP3K14, HSPA1B, HSPA1A |
| mmu04141:protein processing in endoplasmic reticulum | 5 | 0.001406 | PPP1R15A, DNAJB1, HSPA8, HSPA1B, HSPA1A |
| mmu03040:spliceosome | 4 | 0.006952 | HSPA8, SNRNP200, HSPA1B, HSPA1A |
| mmu04612:antigen processing and presentation | 3 | 0.024577 | HSPA8, HSPA1B, HSPA1A |
| mmu04915:estrogen signaling pathway | 3 | 0.034176 | HSPA8, HSPA1B, HSPA1A |
| mmu04110:cell cycle | 3 | 0.052334 | CCNB1, SMAD3, MYC |
| mmu05134:legionellosis | 3 | 0.012357 | HSPA8, HSPA1B, HSPA1A |
| mmu05164:influenza A | 4 | 0.013793 | DNAJB1, HSPA8, HSPA1B, HSPA1A |
| mmu05205:proteoglycans in cancer | 4 | 0.021748 | MYC, FLNA, FLNB, HSPG2 |
| mmu05132: | 3 | 0.022385 | TJP1, FLNA, FLNB |
| mmu05145:toxoplasmosis | 3 | 0.038769 | HSPA8, HSPA1B, HSPA1A |
| mmu04144:endocytosis | 4 | 0.04145 | HSPA8, SMAD3, HSPA1B, HSPA1A |
| mmu05166:HTLV-I infection | 4 | 0.047645 | SMAD3, MYC, MAP3K14, POLE |
| mmu05162:measles | 3 | 0.06166 | HSPA8, HSPA1B, HSPA1A |
Gene ontology enrichment analysis on GC-1 and TM4 common deregulated genes.
| Term | Count | Genes | |
| GO:2001022∼positive regulation of response to DNA damage stimulus | 2 | 0.031782 | BCLAF1, MYC |
| GO:0006974∼cellular response to DNA damage stimulus | 5 | 0.03441 | TOP2A, ATAD5, MYC, ATRX, SMC3 |
| GO:0043066∼negative regulation of apoptotic process | 10 | 3.51E-05 | NPM1, CITED2, DUSP1, NCL, PLK2, CXCR2, FN1, THBS1, CYR61, IER3 |
| GO:0043065∼positive regulation of apoptotic process | 8 | 5.22E-05 | TOP2A, BCLAF1, DUSP1, TRPM7, PTGS2, PHLDA1, CYR61, RHOB |
| GO:0043280∼positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3 | 0.008723 | MYC, CYR61, CTGF |
| GO:0008284∼positive regulation of cell proliferation | 7 | 0.004907 | NPM1, MYC, CXCR2, FN1, PTGS2, THBS1, CTGF |
| GO:0071364∼cellular response to epidermal growth factor stimulus | 3 | 0.004982 | COL1A1, NCL, MYC |
| GO:0007049∼cell cycle | 6 | 0.033428 | DUSP1, MKI67, SMC3, SMC4, SMC2, CD2AP |
| GO:0051383∼kinetochore organization | 2 | 0.008768 | SMC4, SMC2 |
| GO:0010942∼positive regulation of cell death | 3 | 0.008723 | EGR1, PTGS2, CTGF |
| GO:0010628∼positive regulation of gene expression | 7 | 0.001063 | EGR1, HSPA8, CITED2, FUBP1, SERPINE1, FN1, CTGF |
| GO:0045893∼positive regulation of transcription, DNA-templated | 7 | 0.006565 | DDX17, COL1A1, EGR1, NPM1, CITED2, MYC, SMARCA5 |
| GO:0010629∼negative regulation of gene expression | 5 | 0.007523 | NPM1, CITED2, MYC, SERPINE1, CTGF |
| GO:0045944∼positive regulation of transcription from RNA polymerase II promoter | 9 | 0.007997 | DDX17, TOP2A, EGR1, CITED2, NCL, MYC, ATRX, PSIP1, CYR61 |
| GO:0051276∼chromosome organization | 4 | 1.87E-04 | MYC, SMC3, SMC4, SMC2 |
| GO:0045132∼meiotic chromosome segregation | 2 | 0.014571 | SMC4, SMC2 |
| GO:0010032∼meiotic chromosome condensation | 2 | 0.014571 | SMC4, SMC2 |
| GO:0006338∼chromatin remodeling | 3 | 0.022492 | MYC, ATRX, SMARCA5 |
| GO:0001525∼angiogenesis | 7 | 6.84E-05 | SETD2, NCL, SERPINE1, FN1, PTGS2, CTGF, RHOB |
| GO:0032355∼response to estradiol | 5 | 2.18E-04 | COL1A1, DUSP1, MYC, PTGS2, CTGF |
| GO:0051591∼response to cAMP | 4 | 4.48E-04 | COL1A1, SPARC, MAT2A, DUSP1 |
| GO:0030261∼chromosome condensation | 3 | 9.85E-04 | TOP2A, SMC4, SMC2 |
| GO:0048661∼positive regulation of smooth muscle cell proliferation | 4 | 0.001666 | EGR1, MYC, PTGS2, THBS1 |
| GO:0042060∼wound healing | 4 | 0.002641 | COL1A1, SPARC, SERPINE1, FN1 |
| GO:0045766∼positive regulation of angiogenesis | 4 | 0.005367 | SERPINE1, CXCR2, THBS1, RHOB |
| GO:0043085∼positive regulation of catalytic activity | 3 | 0.005828 | HSPA8, NPM1, MYC |
| GO:0010595∼positive regulation of endothelial cell migration | 3 | 0.006425 | SPARC, THBS1, RHOB |
| GO:0035914∼skeletal muscle cell differentiation | 3 | 0.011335 | EGR1, CITED2, MYC |
| GO:0007155∼cell adhesion | 6 | 0.013561 | DST, FN1, THBS1, CYR61, CTGF, RHOB |
| GO:0010757∼negative regulation of plasminogen activation | 2 | 0.014571 | SERPINE1, THBS1 |
| GO:0048146∼positive regulation of fibroblast proliferation | 3 | 0.015584 | MYC, SERPINE1, FN1 |
| GO:0051592∼response to calcium ion | 3 | 0.016973 | SPARC, DUSP1, THBS1 |
| GO:0071636∼positive regulation of transforming growth factor beta production | 2 | 0.017461 | PTGS2, THBS1 |
| GO:0043434∼response to peptide hormone | 3 | 0.0194 | COL1A1, SPARC, CTGF |
| GO:0051918∼negative regulation of fibrinolysis | 2 | 0.020341 | SERPINE1, THBS1 |
| GO:0046599∼regulation of centriole replication | 2 | 0.020341 | NPM1, PLK2 |
| GO:0051384∼response to glucocorticoid | 3 | 0.020409 | SPARC, DUSP1, PTGS2 |
| GO:0030335∼positive regulation of cell migration | 4 | 0.021653 | COL1A1, FN1, THBS1, CYR61 |
| GO:0009749∼response to glucose | 3 | 0.021963 | EGR1, THBS1, CTGF |
| GO:0071347∼cellular response to interleukin-1 | 3 | 0.023026 | MYC, SERPINE1, FN1 |
| GO:1904628∼cellular response to phorbol 13-acetate 12-myristate | 2 | 0.023214 | MYC, RPLP0 |
| GO:0007613∼memory | 3 | 0.024659 | PLK2, TRPM7, PTGS2 |
| GO:0000375∼RNA splicing, via transesterification reactions | 2 | 0.026078 | SCAF11, SRSF10 |
| GO:0030728∼ovulation | 2 | 0.031782 | MYC, PTGS2 |
| GO:0008380∼RNA splicing | 4 | 0.033622 | HSPA8, SCAF11, LUC7L3, SRSF10 |
| GO:0006334(nucleosome assembly | 3 | 0.037334 | NPM1, ATRX, SMARCA5 |
| GO:0003197(endocardial cushion development | 2 | 0.037453 | CITED2, THBS1 |
| GO:0007076(mitotic chromosome condensation | 2 | 0.037453 | SMC4, SMC2 |
| GO:0030336(negative regulation of cell migration | 3 | 0.038648 | CITED2, SERPINE1, RHOB |
| GO:0030194(positive regulation of blood coagulation | 2 | 0.040277 | SERPINE1, THBS1 |
| GO:0050921(positive regulation of chemotaxis | 2 | 0.043092 | FN1, THBS1 |
| GO:0006376(mRNA splice site selection | 2 | 0.043092 | LUC7L3, SRSF10 |
| GO:0007067(mitotic nuclear division | 4 | 0.047549 | SMC3, SMC4, SMC2, CD2AP |
| GO:0046907(intracellular transport | 2 | 0.048698 | RANBP2, DST |
| GO:0070542(response to fatty acid | 2 | 0.054272 | PTGS2, CTGF |
| GO:0006259(DNA metabolic process | 2 | 0.057047 | TOP2A, MKI67 |
| GO:0046697(decidualization | 2 | 0.068067 | CITED2, PTGS2 |
| GO:0007126(meiotic nuclear division | 2 | 0.068067 | MKI67, SMC3 |
| GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway | 2 | 0.068067 | CITED2, THBS1 |
| GO:0043044(ATP-dependent chromatin remodeling | 2 | 0.070802 | SMARCA5, ACTB |
| GO:0001895(retina homeostasis | 2 | 0.070802 | ACTB, ACTG1 |
| GO:0048025(negative regulation of mRNA splicing, via spliceosome | 2 | 0.070802 | NPM1, SRSF10 |
| GO:0010667∼negative regulation of cardiac muscle cell apoptotic process | 2 | 0.07353 | HSPA8, NPM1 |
| GO:0016925∼protein sumoylation | 2 | 0.076249 | TOP2A, RANBP2 |
| GO:0042493∼response to drug | 4 | 0.077109 | COL1A1, MAT2A, PTGS2, THBS1 |
| GO:0007052∼mitotic spindle organization | 2 | 0.078961 | PLK2, SMC3 |
| GO:0007569∼cell aging | 2 | 0.084361 | NPM1, CITED2 |
| GO:0001937∼negative regulation of endothelial cell proliferation | 2 | 0.084361 | SPARC, THBS1 |
| GO:0044344∼cellular response to fibroblast growth factor stimulus | 2 | 0.084361 | COL1A1, MYC |
| GO:0070372∼regulation of ERK1 and ERK2 cascade | 2 | 0.087049 | FN1, CYR61 |
| GO:0033574∼response to testosterone | 2 | 0.089729 | DUSP1, THBS1 |
| GO:0006446∼regulation of translational initiation | 2 | 0.092402 | EIF4A2, EIF1 |
| GO:0006351∼transcription, DNA-templated | 10 | 0.095659 | DDX17, EGR1, HSPA8, BCLAF1, SETD2, CITED2, MYC, FUBP1, ATRX, PSIP1 |
| GO:0051301∼cell division | 4 | 0.09664 | SMC3, SMC4, SMC2, CD2AP |
Different gene clusters involved in similar biological processes.
| SKOV3/COV434 | Biological processes | TM4/GC-1 |
| MYC, HMGA2 | DNA damage response | BCLAF1, TOP2A, ATAD5, MYC, ATRX, SMC3 |
| SMAD3, FLNA, HMGA2, CYR61, HSPA1B | Cell apoptosis | NPM1, CITED2, DUSP1, NCL, PLK2, CXCR2, FN1, THBS1, CYR61, IER3, MYC, CTGF, TOP2A, BCLAF1, TRPM7, PTGS2, PHLDA1, RHOB |
| SMAD3, MYC, PKD1, CCNB1 | Cell cycle | DUSP1, MKI67, SMC3, SMC4, SMC2, CD2AP, MYC |
| SMAD3, SH3BP4, HSPA1A | Cell proliferation | NPM1, MYC, CXCR2, FN1, PTGS2, THBS1, CTGF, COL1A1, NCL, |
| PPP1R15A, HSPA8, SMAD3, HMGA2, HCFC1, FLNA | Gene expression | EGR1, HSPA8, CITED2, FUBP1, SERPINE1, FN1, CTGF, NPM1, MYC, DDX17, COL1A1, SMARCA5 |
KEGG enrichment analysis on GC-1 and TM4 common deregulated genes.
| Term | Count | Genes | |
| mmu04510:focal adhesion | 6 | 7.98E-04 | COL1A1, FN1, FLNB, THBS1, ACTB, ACTG1 |
| mmu04390:hippo signaling pathway | 5 | 0.002025 | MYC, SERPINE1, ACTB, ACTG1, CTGF |
| mmu04512:ECM-receptor interaction | 3 | 0.040363 | COL1A1, FN1, THBS1 |
| mmu04010:MAPK signaling pathway | 4 | 0.061762 | HSPA8, DUSP1, MYC, FLNB |
| mmu05205:proteoglycans in cancer | 7 | 7.28E-05 | COL1A1, MYC, FN1, FLNB, THBS1, ACTB, ACTG1 |
| mmu05100:bacterial invasion of epithelial cells | 4 | 0.002739 | FN1, ACTB, CD2AP, ACTG1 |
| mmu04145:phagosome | 4 | 0.023537 | CD209C, THBS1, ACTB, ACTG1 |
| mmu05132:Salmonella infection | 3 | 0.032375 | FLNB, ACTB, ACTG1 |
| mmu05222:small cell lung cancer | 3 | 0.037085 | MYC, FN1, PTGS2 |
| mmu04919:thyroid hormone signaling pathway | 3 | 0.064117 | MYC, ACTB, ACTG1 |
| mmu04611:platelet activation | 3 | 0.081647 | COL1A1, ACTB, ACTG1 |
| mmu03040:spliceosome | 3 | 0.0838 | HSPA8, SRSF10, U2SURP |
Female reproductive diseases caused by radiation exposure.
| Diseases or functions annotation | # molecules | Molecules | |
| Genital tract cancer | 2.64E-08 | 46 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, BHLHE40, CCN1, CCNB1, CELSR1, CEP170B, CLK1, FLNA, FLNB, HCFC1, HMGA2, HSPA1A/HSPA1B, HSPA8, HSPE1-MOB4, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NACA, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, PPP1R15A, PRRC2B, RHOB, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TJP1, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Genital tumor | 4.45E-08 | 46 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, BHLHE40, CCN1, CCNB1, CELSR1, CEP170B, CLK1, FLNA, FLNB, HCFC1, HMGA2, HSPA1A/HSPA1B, HSPA8, HSPE1-MOB4, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NACA, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, PPP1R15A, PRRC2B, RHOB, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TJP1, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Female genital tract cancer | 1.02E-07 | 40 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, CCN1, CCNB1, CELSR1, CLK1, FLNA, FLNB, HCFC1, HMGA2, HSPA1A/HSPA1B, HSPE1-MOB4, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, RHOB, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TJP1, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Tumorigenesis of reproductive tract | 1.79E-07 | 40 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, CCN1, CCNB1, CELSR1, CLK1, FLNA, FLNB, HCFC1, HMGA2, HSPA1A/HSPA1B, HSPE1-MOB4, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, RHOB, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TJP1, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Female genital tract adenocarcinoma | 2.10E-07 | 37 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, CCNB1, CELSR1, CLK1, FLNA, FLNB, HCFC1, HMGA2, HSPA1A/HSPA1B, HSPE1-MOB4, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Endometrioid endometrial adenocarcinoma | 2.98E-07 | 33 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, CELSR1, FLNA, FLNB, HCFC1, HSPA1A/HSPA1B, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Endometrial cancer | 3.27E-07 | 35 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, CCNB1, CELSR1, FLNA, FLNB, HCFC1, HSPA1A/HSPA1B, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TJP1, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Development of genital tumor | 3.67E-07 | 39 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, CCN1, CCNB1, CELSR1, CLK1, FLNA, FLNB, HCFC1, HMGA2, HSPA1A/HSPA1B, HSPE1-MOB4, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TJP1, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Endometrial carcinoma | 5.26E-07 | 34 | ABHD14A-ACY1, AGAP6 (includes others), AHNAK, ANKRD52, CELSR1, FLNA, FLNB, HCFC1, HSPA1A/HSPA1B, HSPG2, ILF3, KMT2D, LARP1, LENG8, MAP3K14, MSH5, MYC, NBPF10 (includes others), NDST1, NOMO1 (includes others), PKD1, PLEC, POLE, SH3BP4, SMAD3, SNRNP200, SRCAP, SRRM2, TJP1, TMEM189-UBE2V1, TNRC18, TPX2, TRIO, UBR4 |
| Ovarian tumor | 6.44E-05 | 18 | AHNAK, ANKRD52, CCN1, CCNB1, CLK1, HCFC1, HMGA2, HSPE1-MOB4, KMT2D, MYC, PKD1, POLE, RHOB, SMAD3, SNRNP200, SRCAP, TNRC18, TPX2 |
| Ovarian cancer | 1.63E-04 | 17 | AHNAK, ANKRD52, CCN1, CCNB1, CLK1, HCFC1, HMGA2, HSPE1-MOB4, KMT2D, MYC, PKD1, POLE, RHOB, SNRNP200, SRCAP, TNRC18, TPX2 |
| Growth of genital organ | 4.23E-04 | 4 | KMT2D, MYC, NDST1, SMAD3 |
| Growth of ovary | 6.45E-04 | 3 | KMT2D, MYC, SMAD3 |
| Ovarian carcinoma | 1.76E-03 | 14 | AHNAK, ANKRD52, CLK1, HCFC1, HMGA2, HSPE1-MOB4, KMT2D, MYC, PKD1, POLE, SNRNP200, SRCAP, TNRC18, TPX2 |
Male reproductive diseases caused by radiation exposure.
| Diseases or functions annotation | # molecules | Molecules | |
| Malignant neoplasm of male genital organ | 9.69E-07 | 30 | ATAD5, ATRX, BCLAF1, CD2AP, COL1A1, DDX17, DUSP1, EGR1, FLNB, FN1, HSPA8, IER3, LUC7L3, MKI67, MYC, NPM1, PHLDA1, PLK2, PSIP1, PTGS2, RGPD4 (includes others), SETD2, SMC3, SMC4, SPARC, SRSF10, TOP2A, TRPM7, UBC, ZFC3H1 |
| Endometriosis | 3.09E-06 | 9 | ACTB, CITED2, CXCR2, DUSP1, EGR1, FN1, PLK2, PTGS2, TOP2A |
| Prostate cancer | 9.27E-06 | 28 | ATAD5, ATRX, CD2AP, COL1A1, DDX17, DUSP1, EGR1, FLNB, FN1, HSPA8, IER3, LUC7L3, MKI67, MYC, NPM1, PHLDA1, PLK2, PSIP1, PTGS2, RGPD4 (includes others), SETD2, SMC3, SMC4, SPARC, SRSF10, TOP2A, UBC, ZFC3H1 |
| Tumorigenesis of reproductive tract | 9.69E-06 | 36 | ACTB, ACTG1, ATAD5, ATRX, BCLAF1, CD2AP, COL1A1, CXCR2, DUSP1, EIF4A2, FLNB, FN1, FUBP1, IER3, LUC7L3, MKI67, MYC, NPM1, PHLDA1, PLK2, PSIP1, PTGS2, RGPD4 (includes others), RHOB, SCAF11, SERPINE1, SETD2, SMARCA5, SMC3, SMC4, THBS1, TOP2A, TRPM7, U2SURP, UBC, ZFC3H1 |
| Genital tumor | 1.16E-05 | 41 | ACTB, ACTG1, ATAD5, ATRX, BCLAF1, CD2AP, COL1A1, CXCR2, DDX17, DUSP1, EGR1, EIF4A2, FLNB, FN1, FUBP1, HSPA8, IER3, LUC7L3, MKI67, MYC, NPM1, PHLDA1, PLK2, PSIP1, PTGS2, RGPD4 (includes others), RHOB, SCAF11, SERPINE1, SETD2, SMARCA5, SMC3, SMC4, SPARC, SRSF10, THBS1, TOP2A, TRPM7, U2SURP, UBC, ZFC3H1 |
| Morphology of reproductive system | 1.68E-05 | 11 | ATRX, CXCR2, DUSP1, EGR1, FUBP1, MYC, PLK2, PTGS2, SERPINE1, SETD2, THBS1 |
| Prostatic carcinoma | 9.71E-05 | 24 | ATAD5, ATRX, CD2AP, COL1A1, DDX17, DUSP1, FLNB, FN1, HSPA8, LUC7L3, MKI67, MYC, NPM1, PHLDA1, PLK2, PTGS2, RGPD4 (includes others), SETD2, SMC3, SMC4, SRSF10, TOP2A, UBC, ZFC3H1 |
| Development of genital tumor | 1.75E-04 | 33 | ACTB, ACTG1, ATAD5, ATRX, BCLAF1, CD2AP, COL1A1, CXCR2, EIF4A2, FLNB, FN1, FUBP1, IER3, LUC7L3, MKI67, MYC, NPM1, PHLDA1, PLK2, PSIP1, PTGS2, RGPD4 (includes others), SCAF11, SETD2, SMARCA5, SMC3, SMC4, THBS1, TOP2A, TRPM7, U2SURP, UBC, ZFC3H1 |
FIGURE 5The alteration of gene networks is caused by the ionizing radiation. The gene networking of the Ingenuity Pathway Analysis (IPA) showed the gene networks in response to the ionizing radiation in (A) female reproductive cells and (B) male reproductive cells. Red color represented upregulated genes and green color represented downregulated genes. The purple arrow showed the direct transcriptional regulation.